您当前位置：首页 > 国际期刊-EXPERT OPINION ON INVESTIGATIONAL DRUGS期刊投稿发表详细信息

EXPERT OPINION ON INVESTIGATIONAL DRUGS Q1

期刊收录：
SCIE
Scopus

基本信息

期刊ISSN：
1354-3784
期刊简拼：
EXPERT OPIN INV DRUG
年发文章数：
100
E-ISSN：
1744-7658
Gold OA文章占比
11.27%
研究文章占比：
37.00%
是否OA：
No
Jcr分区：
Q1
中科院分区：
2区

出版信息

出版商：
Taylor and Francis Ltd.
涉及研究方向：
医学-药学
出版国家：
ENGLAND
出版语言：
English
出版周期：
Monthly
出版年份：
1994

2023-2024最新影响因子:4.9
自引率:0.00%
五年影响因子:5.3
JCI期刊引文指标:1.03
h-index:94
CiteScore:10.00

期刊关键词

1区 SCIE Scopus 医学 2区 PHARMACOLOGY & PHARMACY 药学

期刊简介

Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.

The Editors welcome:

Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.

《EXPERT OPINION ON INVESTIGATIONAL DRUGS》期刊已被查看：次
期刊简写：EXPERT OPIN INV DRUG

此期刊被最新的JCR期刊SCIE收录